HRMY
Harmony Biosciences Holdings
NASDAQ: HRMY · HEALTHCARE · BIOTECHNOLOGY
$31.26
+0.68% today
Updated 2026-04-30
Market cap
$1.80B
P/E ratio
11.46
P/S ratio
2.07x
EPS (TTM)
$2.71
Dividend yield
—
52W range
$26 – $41
Volume
1.0M
Harmony Biosciences Holdings (HRMY) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-5.4%
Last 4 quarters
Revenue YoY growth
+21.1%
Most recent quarter
EPS YoY growth
-47.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.1%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+4.9%
2026-02-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-24 | $0.57 | -33.7% | $26.87 | $28.19 | +4.9% |
| 2025-10-27 | $1.08 | +32.5% | $30.25 | $29.64 | -2.0% |
| 2025-08-05 | $0.68 | -5.6% | $35.54 | $34.67 | -2.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.86 | $0.57 | -33.7% | $243.78M | +21.1% |
| 2025-09-30 | $0.81 | $1.08 | +32.5% | $239.46M | +28.7% |
| 2025-06-30 | $0.72 | $0.68 | -5.6% | $200.49M | +16.0% |
| 2025-03-31 | $0.91 | $0.78 | -14.8% | $184.73M | +19.5% |
| 2024-12-31 | $0.82 | $1.08 | +32.2% | $201.27M | +19.5% |
| 2024-09-30 | $0.67 | $0.79 | +17.9% | $186.04M | +16.1% |
| 2024-06-30 | $-0.06 | $0.20 | +433.3% | $172.81M | +28.8% |
| 2024-03-31 | $0.60 | $0.67 | +11.7% | $154.62M | — |
| 2023-12-31 | $0.48 | $0.45 | -6.2% | $168.41M | — |
| 2023-09-30 | $0.65 | $0.75 | +15.4% | $160.27M | — |
| 2023-06-30 | $0.63 | $0.56 | -11.1% | $134.22M | — |
Frequently asked questions
Has Harmony Biosciences Holdings beaten earnings estimates?
Harmony Biosciences Holdings has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -5.4% over the last 4 quarters.
How does HRMY stock react to earnings?
HRMY stock has moved an average of +0.1% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Harmony Biosciences Holdings's revenue growth rate?
Harmony Biosciences Holdings reported year-over-year revenue growth of +21.1% in its most recent quarter, with EPS growing -47.2% year-over-year.